Skip to main
SKIN

SKIN Stock Forecast & Price Target

SKIN Analyst Ratings

Based on 4 analyst ratings
Hold
Strong Buy 25%
Buy 0%
Hold 75%
Sell 0%
Strong Sell 0%

Bulls say

SkinHealth Systems is a promising company with a strong ecosystem of clinically validated solutions and a focus on improving skin health for consumers. While there are potential risks related to franchise model and ongoing legal obligations, the company has shown positive growth in its consumables business and is aiming to improve sales and marketing strategies. However, it may take some time for these efforts to result in consistent improvement in device placements and utilization in the field.

Bears say

SkinHealth Systems is facing significant headwinds in terms of lowered guidance and estimate changes, fierce competition in the ever-changing beauty industry, regulatory risks and potential challenges in retaining and growing its customer base. Additionally, there are concerns about the overall macroeconomic climate and key product risks, as the company is heavily reliant on its Hydrafacial platform for sales. With these challenges combined, the outlook for SkinHealth Systems' stock is negative.

SKIN has been analyzed by 4 analysts, with a consensus rating of Hold. 25% of analysts recommend a Strong Buy, 0% recommend Buy, 75% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of The Beauty Health Company and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About The Beauty Health Company (SKIN) Forecast

Analysts have given SKIN a Hold based on their latest research and market trends.

According to 4 analysts, SKIN has a Hold consensus rating as of Aug 9, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $1.52, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $1.52, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

The Beauty Health Company (SKIN)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.